Talphera (NASDAQ:TLPH) Issues Earnings Results, Meets Estimates

Key Points

• Talphera met analysts’ expectations, reporting quarterly earnings of ($0.06) per share.
• Shares fell 4.8% to $1.40 in mid-day trading, despite trading volume exceeding the stock’s average.
• Analyst sentiment remains mixed, resulting in a consensus “Hold” rating and a $3.00 price target; institutional investors own 37.67% of the company.

Talphera (NASDAQ:TLPH - Get Free Report) issued its earnings results on Wednesday. The company reported ($0.06) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.06), FiscalAI reports.

Talphera Stock Down 4.8%

Shares of NASDAQ TLPH traded down $0.07 during mid-day trading on Wednesday, reaching $1.40. 497,231 shares of the company were exchanged, compared to its average volume of 246,501. The stock has a market capitalization of $72.66 million, a P/E ratio of -4.52 and a beta of 0.69. The company's 50-day simple moving average is $1.16 and its 200-day simple moving average is $0.95. Talphera has a twelve month low of $0.40 and a twelve month high of $1.57.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on TLPH shares. Wall Street Zen raised shares of Talphera to a "hold" rating in a research report on Saturday. Zacks Research raised shares of Talphera to a "hold" rating in a report on Monday, June 8th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Talphera in a research note on Friday, July 17th. HC Wainwright began coverage on Talphera in a report on Friday, June 5th. They set a "buy" rating and a $3.00 price target for the company. Finally, Westpark Capital assumed coverage on Talphera in a research report on Thursday, April 30th. They set a "buy" rating and a $3.00 price target on the stock. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $3.00.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Nantahala Capital Management LLC lifted its holdings in Talphera by 75.3% during the 3rd quarter. Nantahala Capital Management LLC now owns 3,492,519 shares of the company's stock worth $3,120,000 after purchasing an additional 1,500,000 shares during the last quarter. Cantor Fitzgerald L. P. bought a new stake in Talphera in the 4th quarter valued at $658,000. Renaissance Technologies LLC grew its holdings in Talphera by 412.6% in the 4th quarter. Renaissance Technologies LLC now owns 257,380 shares of the company's stock valued at $293,000 after buying an additional 207,166 shares in the last quarter. Geode Capital Management LLC grew its holdings in Talphera by 107.0% in the 4th quarter. Geode Capital Management LLC now owns 342,987 shares of the company's stock valued at $391,000 after buying an additional 177,294 shares in the last quarter. Finally, Diadema Partners LP bought a new position in Talphera during the 4th quarter worth $156,000. 37.67% of the stock is owned by institutional investors.

Talphera Company Profile

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source